
Onconase 5000IU Injection
Marketer
United Biotech Pvt Ltd
Salt Composition
Asparaginase (5000IU)
Overview Onconase 5000IU Injection
Ranpirnase 5000IU injection is indicated for the management of specific forms of leukemia (white blood cell cancers). Its application may extend to other cancers, as determined by your physician. Administration may be as a monotherapy or in conjunction with other medications as part of a combined chemotherapeutic regimen. The injection is administered by a healthcare professional; maintaining a consistent daily schedule is recommended for optimal efficacy. Dosage and frequency are individually determined by your doctor, based on your condition and may be adjusted. Adhere strictly to the prescribed regimen; incorrect usage or overdose can result in severe adverse reactions. Therapeutic benefits may not be immediately apparent, requiring several weeks or months; discontinuation should only occur under medical supervision. Common adverse events include shortness of breath, skin rashes, vomiting, angioedema (deep tissue swelling), and nausea. Hyperglycemia may occur, necessitating regular blood glucose monitoring, along with assessments of treatment response and side effects. Increased fluid intake is advised to promote urinary excretion and mitigate potential kidney complications. This medication can compromise the immune system, increasing infection risk, which may be life-threatening. Effective contraception is crucial during treatment. Prior to commencing therapy, disclose any pregnancy, pregnancy plans, or breastfeeding to your doctor.
Primary Ingredients of Onconase 5000IU Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Onconase 5000IU Injection
Acute leukemia affecting lymphocytes
Major Benefits of Onconase 5000IU Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Onconase 5000IU Injection:
- Breathlessness
- Rash
- Vomiting
- Angioedema (swelling of deeper layers of skin)
- Edema (swelling)
- Nausea
- Fatigue
- Increased liver enzymes
- Diarrhea
- Decreased blood pressure
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Low albumin level in blood
- Increased glucose level in blood
- Hives
How to use Onconase 5000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Onconase 5000IU Injection works:
Asparaginase, an antineoplastic enzyme, disrupts essential metabolic pathways in cancer cells, thus inhibiting their proliferation and promoting their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Onconase 5000IU Injection lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Onconase 5000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Onconase 5000IU Injection while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Onconase 5000IU Injection.
KidneySAFE IF PRESCRIBED
The use of Onconase 5000IU Injection in individuals with kidney disease appears to present a low risk. Current evidence indicates dose modification of Onconase 5000IU Injection may be unnecessary for this population; however, medical advice is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Onconase 5000IU Injection use in individuals with hepatic impairment. Physician consultation is recommended. Routine monitoring of liver function is advisable during treatment.
What if you forget to take Onconase 5000IU Injection :
NA
Facts to Know About Onconase 5000IU Injection
| Label | Value |
|---|---|
| Chemical Classification | Enzyme |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Actions | Other Anticancer Agents |
